BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9136072)

  • 1. p-value adjustments for subgroup analyses.
    Bristol DR
    J Biopharm Stat; 1997 May; 7(2):313-21; discussion 323-31. PubMed ID: 9136072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A flexible strategy for testing subgroups and overall population.
    Alosh M; Huque MF
    Stat Med; 2009 Jan; 28(1):3-23. PubMed ID: 18985704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjusted significance levels for subgroup analyses in clinical trials.
    Spiessens B; Debois M
    Contemp Clin Trials; 2010 Nov; 31(6):647-56. PubMed ID: 20832503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges of subgroup analyses in multinational clinical trials: experiences from the MERIT-HF trial.
    Wedel H; Demets D; Deedwania P; Fagerberg B; Goldstein S; Gottlieb S; Hjalmarson A; Kjekshus J; Waagstein F; Wikstrand J;
    Am Heart J; 2001 Sep; 142(3):502-11. PubMed ID: 11526365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primer: the fallacy of subgroup analysis.
    Guillemin F
    Nat Clin Pract Rheumatol; 2007 Jul; 3(7):407-13. PubMed ID: 17599075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of multiplicity adjustment strategies for correlated binary endpoints.
    Leon AC; Heo M
    J Biopharm Stat; 2005; 15(5):839-55. PubMed ID: 16080237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Multiplicity of inferences in clinical trials: adjustment methods, clinical interpretation issues].
    Jouan-Flahault C; Casset-Semanaz F; Minini P
    Med Sci (Paris); 2004 Feb; 20(2):231-5. PubMed ID: 14997445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction effects and subgroup analyses in clinical trials: more than meets the eye?
    Sevdalis N; Jacklin R
    J Eval Clin Pract; 2008 Oct; 14(5):919-22. PubMed ID: 18373582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adaptive covariate adjustment in clinical trials.
    Wang SJ; Hung HM
    J Biopharm Stat; 2005; 15(4):605-11. PubMed ID: 16022166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subgroup analyses in randomized trials: risks of subgroup-specific analyses; power and sample size for the interaction test.
    Brookes ST; Whitely E; Egger M; Smith GD; Mulheran PA; Peters TJ
    J Clin Epidemiol; 2004 Mar; 57(3):229-36. PubMed ID: 15066682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Misuse of baseline comparison tests and subgroup analyses in surgical trials.
    Bhandari M; Devereaux PJ; Li P; Mah D; Lim K; Schünemann HJ; Tornetta P
    Clin Orthop Relat Res; 2006 Jun; 447():247-51. PubMed ID: 16672904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subgroups: time to go back to basic statistical principles?
    Keene ON; Garrett AD
    J Biopharm Stat; 2014; 24(1):58-71. PubMed ID: 24392978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compliance in clinical trials: impact on design, analysis and interpretation.
    Pledger GW
    Epilepsy Res Suppl; 1988; 1():125-33. PubMed ID: 3072187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relevance of subgroup-specific treatment effects: the Studies Of Left Ventricular Dysfunction (SOLVD) revisited.
    Parker AB; Yusuf S; Naylor CD
    Am Heart J; 2002 Dec; 144(6):941-7. PubMed ID: 12486418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A general method for describing sources of variance in clinical trials, especially operator variance, in order to improve transfer of research knowledge to practice.
    Chambers DW; Leknius C; Reid L
    J Prosthodont; 2009 Apr; 18(3):265-71. PubMed ID: 19141049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Meta-analysis as a tool for gaining knowledge].
    Koch A; Ziegler S
    Med Klin (Munich); 2000 May; 95(1 Spec No):83-90. PubMed ID: 10851854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An overview of statistical planning to address subgroups in confirmatory clinical trials.
    Koch GG; Schwartz TA
    J Biopharm Stat; 2014; 24(1):72-93. PubMed ID: 24392979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Test for the consistency of noninferiority from multiple clinical trials.
    Yan X; Wang MC; Su X
    J Biopharm Stat; 2007; 17(2):265-78. PubMed ID: 17365223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of the limitations of statistical analysis of treatment outcomes used in periodontal research.
    Galgut PN
    J Int Acad Periodontol; 2003 Oct; 5(4):92-7. PubMed ID: 14604057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subgroup analyses in therapeutic cardiovascular clinical trials: are most of them misleading?
    Hernández AV; Boersma E; Murray GD; Habbema JD; Steyerberg EW
    Am Heart J; 2006 Feb; 151(2):257-64. PubMed ID: 16442886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.